Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Prolonged compared to native FOXO4 peptide (due to retro‑inverso design)
Delivery
Subcutaneous injection (after reconstitution in bacteriostatic water or suitable solvent)
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
FOX04‑DRI (Retro‑Inverso) is a synthetic peptide designed to interfere with the FOXO4/p53 interaction, enabling selective induction of apoptosis in senescent cells to improve tissue function and biological age.
Used in research to remove senescent cells and study aging, tissue regeneration, insulin signaling, and cell cycle control.
Acts as a cell‑penetrating peptide that disrupts FOXO4 binding to p53, freeing p53 to induce apoptosis in senescent cells.
FOX04‑DRI (Retro‑Inverso) is a synthetic peptide designed to interfere with the FOXO4/p53 interaction, enabling selective induction of apoptosis in senescent cells to improve tissue function and biological age.
FOX04-DRI (10 mg) has an approximate half-life of Prolonged compared to native FOXO4 peptide (due to retro‑inverso design). The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
FOX04-DRI (10 mg) is typically delivered via subcutaneous injection (after reconstitution in bacteriostatic water or suitable solvent). The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
Acts as a cell‑penetrating peptide that disrupts FOXO4 binding to p53, freeing p53 to induce apoptosis in senescent cells.
Studied benefits of FOX04-DRI (10 mg) include: Selective clearance of senescent cells, Improved organ and tissue function, Reduced aging‑related inflammatory signaling, Enhanced insulin sensitivity and metabolic outcomes. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of FOX04-DRI (10 mg) include: Limited human safety data, Potential off‑target effects in non‑senescent cells. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Other peptide compounds in the Peptides Calculator library.
Half-life · About 7 days
Half-life · ≈3–5 minutes
Half-life · 3–10 minutes in plasma, longer central nervous effects
Half-life · 2 hours (approx.)
Half-life · Approximately 8 days
Half-life · 2–4 hours (in animal studies; human data not established)